Keith Eaton

Fred Hutchinson Cancer Research Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (17)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (5)

Catherine Fedorenko

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Delvys Rodriguez-Abreu

Universidad de Las Palmas de Gran Canaria

SPAIN

View details

Timothy Burns

Assistant Professor

University of Pittsburgh

UNITED STATES

View details

Rosalyn Juergens

CANADA

View details

Hossein Borghaei

Professor and Chief, Thoracic Oncology

Fox Chase Cancer Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Keith Eaton

Research Interests

Explore related searches

Contact this professor

Articles (17)

Phase I/II Trial of Exportin 1 Inhibitor Selinexor plus Docetaxel in Previously Treated, Advanced KRAS-Mutant Non–Small Cell Lung Cancer

Impact of institutional interventions on the rate of paclitaxel hypersensitivity reactions

Molecular phenotyping of small cell lung cancer using targeted cfDNA profiling of transcriptional regulatory regions

SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer

Central line patency: Management with normal saline flushes for adult patients with cancer

Central Line Patency: Management With Normal Saline Flushes for Adult Patients With Cancer.

Mocetinostat in Combination With Durvalumab for Patients With Advanced NSCLC: Results From a Phase I/II Study

Impact of Diagnostic Delays on Lung Cancer Survival Outcomes: A Population Study of the US SEER-Medicare Database

Development of Neuropathic Arthropathy With Entrectinib: Case Report

First-in-human phase 1/1b study to evaluate sitravatinib in patients with advanced solid tumors

High End-of-Life Health Care Utilization in a Contemporary Cohort of Head and Neck Cancer Patients Treated with Immune Checkpoint Inhibitors

Impact of Clinical Trial Participation on Survival of Patients with Metastatic Non-Small Cell Lung Cancer

Effect of Clinical Trial Participation on Costs to Payers in Metastatic Non–Small-Cell Lung Cancer

A case series of morbid COPD exacerbations during immune checkpoint inhibitor therapy in cancer patients

A phase II trial of pembrolizumab and vorinostat in recurrent metastatic head and neck squamous cell carcinomas and salivary gland cancer

Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma

MYCN drives chemoresistance in small cell lung cancer while USP7 inhibition can restore chemosensitivity

Collaborators (5)

Catherine Fedorenko

Delvys Rodriguez-Abreu

Timothy Burns

Rosalyn Juergens

Hossein Borghaei

Make your next move.